Cancer-related death in colorectal cancer CRC is usually due to the development of distant metastases. Approximately 70 of all patients diagnosed with CRC undergo potentially curative surgery, but half of these patients present with, or develop, advanced local disease or metastases 1 . Although several prognostic factors exist, including the clinical staging classi cation, a more speci c recognition marker for CRC with high metastatic potential would provide useful information for evaluating adjuvant therapies. We have already reported a correlation between the immunohistochemical expression of CD44 and lymph node and liver metastases 2 , and more speci c markers are required.
formed cells 3, 4 . L-type amino acid transporter 1 LAT1 , one of the L-type amino acid transporters, transports large neutral amino acids such as leucine, isoleucine, valine, phenylalanine, tyrosine, tryptophan, methinine and histidine 5-7 .
LAT1 expression is closely related to liver metastases in a rat tumor model 8 , but little is known about this relationship in human primary digestive organ tumors 9 . The aim of the present study was to examine LAT1 expression in CRC with invasion to the subserosal layer T3 , and its relationship with potential liver metastases and associated clinicopathological characteristics. Because liver metastasis occurs more frequently in T3 than in T1
invasion to the submucosal layer or T2 invasion to the muscular layer tumors, it is important to clarify whether LAT1 expression in cancer cells would be a good marker for predicting potential liver metastasis in T3 CRC. A B
Materials and Methods
Tissue samples from 65 patients who had primary T3 CRC surgically resected at the Showa University Hospital between 2004 and 2007 were enrolled in this retrospective study. The non-necrotic portion of the tumor was processed using the standard paraf n wax technique after xation in 10 formalin for 24 hours. Representative sections were stained with hematoxylin and eosin. T1, T2, and T4 invasion to the serosa tumors were not examined, because suf cient cases could not be collected for meaningful statistical analysis. is widely used by many authors 9, 10 . All histological slides were examined by two experienced pathologists unaware of the clinical data or disease outcome.
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Statistical analysis
The association of LAT1 expression with clinicopathological features, such as age, gender, tumor location, tumor size, macroscopic / microscopic classi cation, lymph node metastasis and liver metastasis 1 , was examined using the 2 test as appropriate. P 0.05 was considered statistically signi cant.
Results
The characteristics of the study population are shown in 
Discussion
LAT1 expression is associated with cancerous or proliferative cells, and LAT1 is suggested to be involved in the mechanism allowing continuous proliferation of tumor cells 6, 7 . and concluded that LAT1 expression is a signi cant factor in predicting a poor prognosis.
Sakata and colleagues 17 also found a poor prognosis in LAT1-positive prostate cancer cases, and concluded that LAT1 was a novel biomarker for high-grade malignancy. However little is known about the clinical significance of LAT1 expression in digestive system cancers, especially CRC 9 .
In rat colonic cancer models, LAT1 expression has been described as being associated with metastasis in vivo 8, 18 . When rat colon cancer cells RCN-9 were injected into the spleen of rats, the size of the resultant metastatic liver tumors was directly correlated with LAT1 expression 8, 18 . These studies support our nding that LAT1 expression showed a signi cantly positive relationship with liver metastasis in patients with T3 CRC. There is only one previous report concerning LAT1 expression in human CRC. Kaira et al 9 examined
LAT1, CD98 and Ki-67 expression in pulmonary metastases from colon cancer and other cancers, and reported that cancer cells in the metastatic foci showed higher LAT1 expression, indicating higher angiogenesis and cell proliferation, than those in the primary foci.
In contrast to the report of Kaira et al 9 References
